{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:23:40Z","timestamp":1760077420267},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2019,9,15]]},"DOI":"10.1007\/s12029-017-0044-5","type":"journal-article","created":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T22:40:17Z","timestamp":1514846417000},"page":"564-567","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gallbladder Cancer: Complete Resection after Second Line Treatment in Stage IV Disease"],"prefix":"10.1007","volume":"50","author":[{"given":"Maria","family":"Castelo Branco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Estevinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Correia Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrinalini","family":"Honavar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Raposo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Catarina","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Sottomayor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,1]]},"reference":[{"key":"44_CR1","first-page":"1373","volume-title":"Abeloff's clinical oncology","author":"JE Niederhuber","year":"2014","unstructured":"Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE. Abeloff's clinical oncology. 5th ed. Philadelphia: Elsevier; 2014. p. 1373\u201396.","edition":"5"},{"issue":"supplement 5","key":"44_CR2","doi-asserted-by":"publisher","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","volume":"27","author":"F Eckel","year":"2016","unstructured":"Eckel F, Brunner T, Jelic S. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2016;27(supplement 5):v28\u201337. https:\/\/doi.org\/10.1093\/annonc\/mdw324.","journal-title":"Annals of Oncology"},{"key":"44_CR3","unstructured":"NCCN Guidelines hepatobiliary cancers, version 2.2016."},{"issue":"6","key":"44_CR4","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1572-0241.2000.02070.x","volume":"95","author":"S Sheth","year":"2000","unstructured":"Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol. 2000;95(6):1402\u201310. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.02070.x.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"44_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ejso.2010.05.002","volume":"36","author":"SV Shrikhande","year":"2010","unstructured":"Shrikhande SV, Barreto SG, Singh S, Udwadia TE, Agarwal AK. Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause. Eur J Surg Oncol. 2010;36(6):514\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2010.05.002.","journal-title":"Eur J Surg Oncol"},{"key":"44_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/CLEP.S37357","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99\u2013109. https:\/\/doi.org\/10.2147\/CLEP.S37357.","journal-title":"Clin Epidemiol"},{"issue":"6","key":"44_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/sj.bjc.6603648","volume":"96","author":"F Eckel","year":"2007","unstructured":"Eckel F, Schmid RM. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer. 2007;96(6):896\u2013902. https:\/\/doi.org\/10.1038\/sj.bjc.6603648.","journal-title":"Br J Cancer"},{"issue":"14","key":"44_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. ABC-02 trial investigators cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381. https:\/\/doi.org\/10.1056\/NEJMoa0908721.","journal-title":"N Engl J Med"},{"issue":"8","key":"44_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/CAD.0b013e3283637292","volume":"24","author":"R Yang","year":"2013","unstructured":"Yang R, Wang B, Chen YJ, et al. Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a metanalysis. Anti-Cancer Drugs. 2013;24(8):871\u20137. https:\/\/doi.org\/10.1097\/CAD.0b013e3283637292.","journal-title":"Anti-Cancer Drugs"},{"issue":"12","key":"44_CR10","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/cncr.21591","volume":"104","author":"JY Cho","year":"2005","unstructured":"Cho JY, Paik YH, Chang YS. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced\/metastatic biliary tract carcinoma. Cancer. 2005;104(12):2753\u20138. https:\/\/doi.org\/10.1002\/cncr.21591.","journal-title":"Cancer"},{"issue":"10","key":"44_CR11","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1200\/JCO.2005.51.008","volume":"23","author":"J Knox","year":"2005","unstructured":"Knox J, Hedley D, Oza A, et al. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. JCO. 2005;23(10):2332\u20138. https:\/\/doi.org\/10.1200\/JCO.2005.51.008.","journal-title":"JCO"},{"issue":"6","key":"44_CR12","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/cncr.22902","volume":"110","author":"RP Riechelmann","year":"2007","unstructured":"Riechelmann RP, Townsley CA, Chin SN, Pond GR, Knox JJ. Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer. Cancer. 2007;110(6):1307\u201312. https:\/\/doi.org\/10.1002\/cncr.22902.","journal-title":"Cancer"},{"issue":"6","key":"44_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s00280-011-1657-1","volume":"68","author":"S Iqbal","year":"2011","unstructured":"Iqbal S, Rankin C, Lenz H, et al. A phase II trial of gemcitabine and capecitabine in patients with unressectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group Study S0202. Cancer Chemother Pharmacol. 2011;68(6):1595\u2013602. https:\/\/doi.org\/10.1007\/s00280-011-1657-1.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"44_CR14","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/cam4.299","volume":"3","author":"F Fiteni","year":"2014","unstructured":"Fiteni F, Nguyen T, Vernerey D, Paillard M, et al. Cisplatin\/gemcitabine or oxaliplatin\/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review. Cancer Med. 2014;3(6):1502\u201311. https:\/\/doi.org\/10.1002\/cam4.299.","journal-title":"Cancer Med"},{"issue":"4","key":"44_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00534-006-1187-0","volume":"14","author":"H Nishio","year":"2007","unstructured":"Nishio H, Nagino M, Ebata T, Yokoyama Y, Igami T, Nimura Y. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepato-Biliary-Pancreat Surg. 2007;14(4):351\u20137. https:\/\/doi.org\/10.1007\/s00534-006-1187-0.","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"issue":"12","key":"44_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1477-2574.2012.00544.x","volume":"14","author":"MJ Kang","year":"2012","unstructured":"Kang MJ, Song Y, Jang J, et al. Role of radical surgery in patients with stage IV gallbladder cancer. HPB. 2012;14(12):805\u201311. https:\/\/doi.org\/10.1111\/j.1477-2574.2012.00544.x.","journal-title":"HPB"},{"issue":"5","key":"44_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jamcollsurg.2016.12.058","volume":"224","author":"JM Creasy","year":"2017","unstructured":"Creasy JM, Goldman DA, Dudeja V, Lowery MA, Cercek A, Balachandran VP, et al. Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes. J Am Coll Surg. 2017;224(5):906\u201316. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2016.12.058.","journal-title":"J Am Coll Surg"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-017-0044-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-017-0044-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-017-0044-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:00:41Z","timestamp":1628600441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-017-0044-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9,15]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1007\/s12029-017-0044-5","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,1]]},"assertion":[{"value":"1 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}